Author Archives: flybrand1976

For medical / healthcare professionals in need of protective gear, or perhaps without PAPR gear. Several groups have shown this approach to be valid to protecting the wearer from the disease. The images below link to a Pall element, and … Continue reading →

These are my personal views and not that of any employer. The best resource on this is the summary from the Smart Air Filters website by their CEO, Paddy Robertson.  If you want to approach problem solving in manufacturing – start with Goldratt. … Continue reading →

I am not an expert in this space, but my credentials are reasonable. This is my personal outlook, not that of any employer. There are heartbreaking stories of hospitals calling for PPE – especially facemasks – and courageous stories of … Continue reading →

I am not the author of these posts – they are from the Smart Air Filters website by their CEO, Paddy Robertson. With the COVID-19 and Corona Virus emergency, many are struggling to download these articles to make use of … Continue reading →

[I’m not an expert, but based on the degree of panic and activity and Corona Virus, I’m writing this in an attempt to be helpful.] Assumptions: The virus does not survive as an aerosol like measles, but it does appear … Continue reading →

I’ve spent nearly 15 years working with porous materials – helping companies develop improved porous material products, designing the production systems that deliver membranes and nonwovens, and overseeing these supply chains. I am not a facemask expert – but I’ve … Continue reading →

Goldratt teaches that to improve a system, we must identify the constraints, and then systematically work to relieve them. There are several constrains in the global pandemic: Is the information about the Coronavirus accurate? How does it spread? (It does … Continue reading →

Goldratt teaches that systems should be judged by their output, addressed at the highest level, and constraints should be removed. For a patient that has the disease, some treatment options are emerging. Remdesivir: Nucleotide analog Produced by Gilead, this class … Continue reading →

As SARS-2 containment and COVID19 treatment increase in importance – many global, regional and national systems are activating, cooperating and working towards solutions. The complexity begs for an application of Goldratt’s principles: Pick a Goal. Identify constraints between the current … Continue reading →